These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36200629)

  • 21. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
    J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
    Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
    Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1.
    van Lierop ZYGJ; Verberk IMW; van Uffelen KWJ; Koel-Simmelink MJA; In 't Veld L; Killestein J; Teunissen CE
    Clin Chem Lab Med; 2022 May; 60(6):842-850. PubMed ID: 35333481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
    Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
    J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of Selected Biomarkers in Cerebrospinal Fluid During Complex Endovascular Aortic Repair - A Pilot Study.
    Jónsson GG; Marklund N; Blennow K; Zetterberg H; Wanhainen A; Lindström D; Eriksson J; Mani K
    Ann Vasc Surg; 2022 Jan; 78():141-151. PubMed ID: 34175417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
    Camara-Lemarroy C; Silva C; Gohill J; Yong VW; Koch M
    Eur J Neurol; 2023 Jan; 30(1):187-194. PubMed ID: 36214614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study.
    Simone M; De Giacomo A; Palumbi R; Palazzo C; Lucisano G; Pompamea F; Micella S; Pascali M; Gabellone A; Marzulli L; Giordano P; Gargano CD; Margari L; Frigeri A; Ruggieri M
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Serum Neurofilament Light and Glial Fibrillary Acidic Protein Levels and Head Impact Burden in Women's Collegiate Water Polo.
    Huibregtse ME; Sweeney SH; Stephens MR; Cheng H; Chen Z; Block HJ; Newman SD; Kawata K
    J Neurotrauma; 2023 Jun; 40(11-12):1130-1143. PubMed ID: 36259456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohort.
    Stukas S; Cooper J; Higgins V; Holmes D; Adeli K; Wellington CL
    Clin Chem Lab Med; 2024 Mar; 62(4):698-705. PubMed ID: 37882772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
    Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury.
    Andersson E; Öst M; Dalla K; Zetterberg H; Blennow K; Nellgård B
    Neurocrit Care; 2024 May; ():. PubMed ID: 38769253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury.
    Tigchelaar S; Gupta R; Shannon CP; Streijger F; Sinha S; Flibotte S; Rizzuto MA; Street J; Paquette S; Ailon T; Charest-Morin R; Dea N; Fisher C; Dvorak MF; Dhall S; Mac-Thiong JM; Parent S; Bailey C; Christie S; Van Keuren-Jensen K; Nislow C; Kwon BK
    J Neurotrauma; 2019 Aug; 36(15):2358-2371. PubMed ID: 30827169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein.
    Kim S; Lee JJ; Park JS; Kang M; Seok HY
    Neurol Sci; 2024 Mar; 45(3):1255-1261. PubMed ID: 38141119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on critical care for acute spinal cord injury in the setting of polytrauma.
    Yue JK; Winkler EA; Rick JW; Deng H; Partow CP; Upadhyayula PS; Birk HS; Chan AK; Dhall SS
    Neurosurg Focus; 2017 Nov; 43(5):E19. PubMed ID: 29088951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.
    Kuhle J; Gaiottino J; Leppert D; Petzold A; Bestwick JP; Malaspina A; Lu CH; Dobson R; Disanto G; Norgren N; Nissim A; Kappos L; Hurlbert J; Yong VW; Giovannoni G; Casha S
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):273-9. PubMed ID: 24935984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.
    Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE
    J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
    Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
    J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin reduces neural tissue damage and promotes astrocyte activation after spinal cord injury in rats.
    Wang Y; Li W; Wang M; Lin C; Li G; Zhou X; Luo J; Jin D
    J Cell Biochem; 2018 Feb; 119(2):2298-2306. PubMed ID: 28865131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.
    Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM
    Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.